BridgeMD
COVARIAN : Contribution of contrast enhanced ultrasound for diagnosis of adnexal torsion
EU CTIS ID: 2024-511720-13-00
What this study is testing
To evaluate a two-stage diagnostic strategy including the contrast evaluation of ultrasound compared to the standard diagnostic strategy (without contrast evaluation of ultrasound) in case of strong suspicion of adnexal torsion on performing wrongly surgery, defined by performing emergency surgery (within 6 hours) without proven torsion. A strong suspicion of adnexal torsion is defined when there is a diagnostic doubt after standard assessment or when surgery is considered.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- - Age 18 or over - Person who has carried out a preliminary clinical examination adapted to the clinical trial - Strong suspicion of adnexal torsion with surgery planned, - No ongoing pregnancy or breastfeeding, - Affiliation to or beneficiary of a social security scheme, - Person who has received complete information on the organization
You likely can't join if
- - Non-French-speaking person - Any medical situation that does not indicate the administration of SonoVue®, including: o Known hypersensitivity to sulphur hexafluoride or any of the other components of SonoVue o Woman with acute coronary syndrome or unstable ischemic heart disease o Woman with acute endocarditis o Woman with valve prostheses o Women with acute systemic inflammatory disease and/or sepsis o Woman with hypercoagulation and/or recent thromboembolic accident o End-stage woman with kidney or liver disease o Woman with right-left shunt, severe pulmonary hypertension (pulmonary arterial pressure > 90 mmHg) o Women with uncontrolled systemic hypertension o Woman with respiratory distress syndrome o Medical condition contraindicating the administration of SonoVue®, - History of PEG allergy (or macrogol) - Person referred to in Articles 10, 31, 32, 33 and 34 of Regulation EU 536/2014
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.